Search

Background/Objectives: Benign prostatic hyperplasia (BPH) has a significant impact on the quality of life of symptomatic patients. In patients manifesting lower urinary tract symptoms (LUTS), prostatic arterial embolization (PAE) has become a topic of interest in recent years. The purpose of this systematic review is to analyze and review techniques and clinical outcomes of patients who underwent endovascular treatment of BPH, with a special focus on the comparison of surgical and endovascular procedures. Methods: Through the major scientific databases, 1225 articles were selected from the initial research utilizing specific keywords and medical subject headings. Based on the inclusion and exclusion criteria established for selecting relevant studies for our purposes, the systematic analysis of the literature was conducted on a total of seven articles. Results: We collected data on 718 male patients (408 patients underwent PAE and 310 received TURP). The technical success rate varied from 86% to 100% for TAE and was 100% for TURP. During a 12-month follow-up period, both PAE and TURP were comparable on the reduction in IPSS and QoL questionnaire, while TURP showed significant improvements in Qmax and in the reduction in prostate volume. Length and cost of hospitalization were lower for PAE. Complication and adverse events rates were higher in the TURP group rather than in the PAE group (60.6% vs. 35.5%). Conclusions: Prostatic artery embolization represents an emerging minimally invasive procedure for BPH. According to previously released clinical studies, quality-of-life and urological symptom scores of the PAE group were comparable to those of the TURP group. Our research strengthens the evidence supporting the effectiveness and safety of PAE as a therapy for LUTS related to BPH. [ABSTRACT FROM AUTHOR]

This article, published in the Arab Journal of Interventional Radiology, discusses the use of Superior Hypogastric Plexus Block (SHPB) as a method of pain management after uterine artery embolization (UAE) for uterine fibroids. The study evaluated 27 patients who underwent UAE, with one group receiving SHPB along with opioids and another group receiving opioids only. The results showed that the group receiving SHPB had significantly better pain control compared to the group receiving opioids only. Additionally, within the SHPB group, those with a triangular shape opacification of the superior hypogastric plexus (SHP) had better pain control compared to those with an oval shape opacification. Overall, the study suggests that SHPB is an effective tool for improving pain control after UAE. [Extracted from the article]